Derm Clinic of Dr. Robern

Ottawa, Ontario K2G 6E2

0 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis

Studies at this site

• Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2) — Completed